Global Magnetic Resoannce Imaging Systems Market Share Grows at a Staggering CAGR of 5.3%

Introduction

Magnetic Resonance Imaging (MRI) systems are advanced diagnostic devices that use strong magnetic fields and radio waves to generate detailed images of internal body structures, aiding in the detection and monitoring of various medical conditions. The magnetic resonance imaging systems market is witnessing steady growth, driven by rising diagnostic imaging needs, technological advancements, and the increasing prevalence of chronic diseases globally.

Market Dynamics

Increasing prevalence of brain disorders drives the demand for magnetic resonance imaging systems market

The high burden of brain tumors and focal epilepsy, which causes seizures to spread from the part of the brain, drives the demand for magnetic resonance imaging systems market, especially for diagnostic and monitoring applications, as the need for early and accurate detection has increased.

• For instance, as per the reported data of Brain Research UK, across 12,300 people are diagnosed with primary brain tumour every year, hence signifying the growing demand for MRI technology.
• Further, in March 2025, as per the article published in UKRI, around 360,000 people in UK suffer from the condition of focal epilepsy, which is also the sixth most common reason for hospital admission in UK. So, doctors at Addenbrooke's Hospital, Cambridge use ultra-high filed 7T MRI scanners, that offer detailed resolution of brain scans in patients with drug-resistant epilepsy, hence offering early detection as well as diagnosis of the disease.

Thus, high burden of brain disorders not only in UK but throughout the world propels the demand for MRI devices for accurate diagnosis and monitoring of the condition.

Integration of AI with magnetic resonance imaging systems: Key market opportunity

Integration of AI with magnetic resonance imaging systems, increases the demand for MRI systems that are efficient as well as conserve resources, which further presents as a significant opportunity for market growth of magnetic resonance imaging systems.

• For instance, in December 2024, Siemens Healthineers Limited expands the 1.5 Tesla Magnetom Flow. Platform, with the introduction of new magnetic resonance imaging (MRI) scanner, as its image reconstruction capabilities, are support by AI, which helps in reducing acquisition times and also improves the image quality.
• For instance, Siemens Healthineers Limited, developed Deep Resolve Boost, that applies AI to image reconstruction and also uses deep learning for the noise reduction to accelerate MRI. Such innovation, enables 73% boost in the scan speed with high resolution MRI, which hence increases clinical productivity by reducing scan times.

The integration of AI into MRI technology significantly enhances imaging speed, quality, and clinical efficiency, which further fuels the market growth. Innovations such as AI-powered reconstruction and noise reduction enhances the rising demand for faster, and high-quality diagnostics.

Regional Analysis

North America accounted for the major share of 38.60% in magnetic resonance imaging systems market, owing to strong healthcare infrastructure, well-established reimbursement schemes, and increasing prevalence of chronic conditions such as neurodegenerative disorders and cancers. Additionally, high adoption of advanced MRI systems, strong presence of leading medical device companies, and robust diagnostic imaging infrastructure further drive market growth in the region. Further, collaboration between manufacturers and hospitals facilitate the flow towards exchange of expertise and exposure to recently developed systems is reshaping the diagnostic imaging capabilities in North America.

The Asia Pacific region is anticipated to grow at fastest CAGR during the forecast period. This growth is driven by rising prevalence of chronic conditions such as cancer and cardiovascular problems, improving healthcare infrastructure, increasing government initiatives, and growing investments in research for developing whole-body MRI. Additionally, expanding access to advanced diagnostic imaging in emerging economies such as China and India is accelerating market growth in the region.

Key Highlights

• The global magnetic resonance imaging systems market was valued at USD 7,004.15 million in 2024. It is estimated to reach USD 11,050.00 million by 2033, growing at a CAGR of 5.3% during the forecast period (2025–2033).
• Based on type, the market is segmented into open systems and closed systems. The closed systems segment accounted for major magnetic resonance imaging systems market share of 78.82%, owing to its ability of producing enhanced image quality, precise diagnostics and continuous investments for the development of closed MRI systems towards development of closed MRI systems.
• Based on field strength, the market is segmented into ultra high, high and low.The high segment dominated the magnetic resonance imaging systems sector with the market share of 50.90%. This growth is driven by increased adoption across the hospitals due to its high image quality and its usage for the research purpose of detailed insights of human body and its functions, which helps in early detection of the neurological disease that further aids in early diagnosis.
• Based on application, the market is segmented into neurology, oncology, cardiology, musculoskeletal diseases, gastrointestinal diseases and others.The neurology segment dominated the magnetic resonance imaging systems sector with the market share of 40.00%. This growth is driven by ongoing research towards the study of neurological disorders, high prevalence rate of neurological disorders which raises demand for magnetic resonance imaging systems.
• Based on end user, the market is segmented into hospitals, imaging centers and others. The hospitals segment accounted for largest share of 62.84%, owing to integration of advanced MRI systems in the hospitals, and installation of high magnetic strength-based MRI systems for more enhanced imaging of diseases in the hospitals.

Competitive Players

GE HealthCare, Siemens Healthineers AG, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Esaote SPA, FUJIFILM Holdings Corporation., AURORA HEALTHCARE US CORP, Shenzhen Anke High-tech Co., Ltd, MinFound Medical Systems Co., Ltd, Synaptive Medical, ASG Superconductors spa, Neusoft Medical Systems Co., Ltd., FONAR Corp., Medonica Co. LTD, HYPERFINE, INC., Time Medical Holding, Shanghai United Imaging Healthcare Co., LTD, SternMed GmbH, Kangda Intercontinental Medical Equipment Co, Ltd, Magnetica Ltd, and others.

Recent Developments

• In December 2024, Hyperfine Inc. expanded global market reach with new distribution partnerships in Europe and Middle East.
• In August 2024, neuro42 received investment from Zynext Ventures to accelerate the progress and bring innovative solutions to patients.

Segmentation

1. By Type
   1. Open System
   2. Closed System
2. By Field Strength
   1. Ultra High
   2. High
   3. Low
3. By Application
   1. Neurology
   2. Oncology
   3. Cardiology
   4. Musculoskeletal Diseases
   5. Gastrointestinal Diseases
   6. Others
4. By End User
   1. Hospitals
   2. Imaging Centers
   3. Others
5. By Region
   1. North America
   2. Europe
   3. Asia-Pacific
   4. Middle East & Africa
   5. Latin America